{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Acylated insulin compound", "item": "https://www.patentleaderboard.com/patent/10597436"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Acylated insulin compound

Acylated insulin compound

US Patent 10597436 · Granted Mar 24, 2020

Estimated economic value: $590,722,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunoglobulin chimeric monomer-dimer hybrids2022
Procoagulant compounds2022
Immunoglobulin chimeric monomer-dimer hybrids2021
Chimeric clotting factors2021
FC receptor (FcRn) binding peptides and uses thereof2020
Acylated insulin compound2019
Acylated insulin compound2019
Acylated insulin compound2019
Procoagulant compounds2019
FC receptor (FcRn) binding peptides and uses thereof2018
Glucagon and GLP-1 co-agonist compounds2018
Glucagon and GLP-1 co-agonist compounds2018